ロード中...
Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study
Severe graft-versus-host disease (GVHD) is an often lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT). The safety of clinical-grade mesenchymal stem cells (MSCs) has been validated, but mixed results have been obtained due to heterogeneity of the MSCs. In this phase I...
保存先:
| 出版年: | Korean J Physiol Pharmacol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Physiological Society and The Korean Society of Pharmacology
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4722192/ https://ncbi.nlm.nih.gov/pubmed/26807024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4196/kjpp.2016.20.1.63 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|